Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Custodiol-N vs Custodiol for organ preservation in kidney, liver and pancreas transplantation
2017-002198-20Phase 3Active
- Sponsor
- Franz Köhler Chemie
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of histidine-tryptophan-ketoglutarate solution (modified) in end-stage kidney disease (ESKD), hepatic disease and diabetes mellitus (DM) (2 arms), sponsored by Franz Köhler Chemie. Primary endpoints: Delayed graft function (kidney) and Graft injury (all organs). Started Oct 2018; status: active.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)
03
Conditions
end-stage kidney disease (ESKD)hepatic diseasediabetes mellitus (DM)
Beyond the preview
Go deeper on 2017-002198-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002198-20.